✦ LIBER ✦

Guidelines for biosimilars open possibility for cheaper versions of approved biologics for cancer

✍ Scribed by Elizabeth Mechcatie

Book ID: 119219254
Publisher: Frontline Medical Communications, Inc.
Year: 2012
Tongue: English
Weight: 102 KB
Volume: 9
Category: Article
ISSN: 1548-5315
DOI: 10.1016/j.cmonc.2012.03.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention of prostate cancer: Guid

Chemoprevention of prostate cancer: Guidelines for possible intervention strategies

✍ E. David Crawford; William R. Fair; Gary J. Kelloff; Michael M. Lieber; Gary J. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

The "natural history" of prostate cancer may bedevil the development of guidelines for chemoprevention interventions. Can strategies be designed to direct agents to those lesions which have the potential to develop localized extension that may become symptomatic or metastatic disease? Of necessity o

US Food and Drug Administration approval

US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins

✍ Marc Cohen; Walter P. Jeske; Jose C. Nicolau; Gilles Montalescot; Jawed Fareed 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 489 KB

Possibilities for transborder cooperatio

Possibilities for transborder cooperation in breast cancer care in Europe: A comparative analysis regarding the content, quality and evidence use of breast cancer guidelines

✍ L. Wennekes; R.P.M.G. Hermens; K. van Heumen; V. Runde; H. Schoelen; H.C.H. Woll 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB